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Common genetic variation
near MC4R is associated with
waist circumference and
insulin resistance
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James Scott5 & Jaspal S Kooner5
We carried out a genome-wide association study (318,237
SNPs) for insulin resistance and related phenotypes in 2,684
Indian Asians, with further testing in 11,955 individuals of
Indian Asian or European ancestry. We found associations
of rs12970134 near MC4R with waist circumference
(P ¼ 1.7  109) and, independently, with insulin resistance.
Homozygotes for the risk allele of rs12970134 have B2 cm
increased waist circumference. Common genetic variation
near MC4R is associated with risk of adiposity and
insulin resistance.
Indian Asians comprise one-quarter of the world’s population and are
projected to account for B40% of the global cardiovascular disease
burden by 2020 (ref. 1). Increased cardiovascular disease risk in Indian
Asians is closely associated with a high prevalence of insulin resistance
and related metabolic disturbances (central adiposity, raised triglycer-
ides, low high-density lipoprotein (HDL) cholesterol and type 2
diabetes)2. The reasons underlying increased insulin resistance
among Indian Asians are not well understood; family studies implicate
an important genetic component3. We carried out a two-stage
genome-wide association study of insulin resistance and related
phenotypes in a population cohort of individuals from the UK of
Indian Asian or European ancestry.
In stage one, we genotyped 318,237 SNPs in 2,684 Indian Asian
men aged 35–75 years from the London Life Sciences Population
(LOLIPOP) study using the Illumina Hap300 BeadChip (Supplemen-
tary Methods and Supplementary Table 1 online). Indian Asians
were selected if all four grandparents originated from the Indian
subcontinent. We carried out single SNP marker tests for association
with ten insulin resistance and related phenotypes: homeostasis model
assessment of insulin resistance (HOMA-IR)4, waist circumference
and waist-hip ratio (as measures of central adiposity), weight, body
mass index, diastolic blood pressure, triglycerides, HDL cholesterol,
type 2 diabetes and composite metabolic syndrome (defined by Adult
Treatment Panel III criteria5). We used principal component analysis
to control for population structure (Supplementary Methods)6. We
identified 31 SNPs associated with one or more of the above
phenotypes at P o 105 (Supplementary Tables 2 and 3 online);
eight were in well-described loci known to influence HDL cholesterol
and triglyceride levels (CETP, GCKR and LPL) and were not tested
further7,8. We carried forward the remaining 23 SNPs for further
testing in stage two, of which 22 were successfully genotyped in 11,955
men and women (7,394 Indian Asian individuals and 4,561 indivi-
duals of European ancestry; Supplementary Table 1).
In stage two and the combined analysis, linear regression analyses
were done under an additive genetic model with age, sex and ethnicity
as covariates; there was no evidence for heterogeneity between the
ethnic groups. For each of the 22 genotyped SNPs, we selected
the phenotype with the most significant association in stage one
for primary testing in stage two data, adopting a conservative
threshold of P o 0.002 for statistical significance on the basis of
Bonferroni correction for 22 SNPs. We confirmed significant
association of SNPs rs12970134, rs4450508, rs477181 and rs502933
Table 1 SNPs showing confirmed association with waist circumference in stage two and the combined analysis
SNP Chr. Position
Nearest
gene Alleles
Risk
allele
Stage one effect size
in cm (95% CI) P
Stage two effect size
in cm (95% CI) P
Combined effect size
in cm (95% CI) P
rs12970134 18 56035730 MC4R AG A 1.48 (0.84, 2.11) 4.6  106 0.74 (0.42, 1.07) 5.5  106 0.88 (0.59, 1.17) 1.7  109
rs477181 18 56047018 MC4R TG G 1.23 (0.54, 1.92) 7.0  106 0.56 (0.24, 0.87) 2.3  104 0.68 (0.40, 0.97) 8.1  107
rs502933 18 56047454 MC4R AC C 1.23 (0.54, 1.93) 6.6  106 0.58 (0.26, 0.89) 1.4  104 0.70 (0.42, 0.99) 4.4  107
rs4450508 18 56064414 MC4R AG A 1.39 (0.79, 2.00) 6.5  106 0.64 (0.34, 0.95) 3.8  105 0.79 (0.52, 1.07) 1.8  108
Genomic context of the SNPs selected for further testing and their association test results against waist circumference (most strongly associated phenotype) in the stage one genome-
wide association study (n ¼ 2,684), the stage two study (n ¼ 11,955) and the combined analysis of stage one and two data (n ¼ 14,639). Effect sizes are shown as change in waist
circumference per copy of high-risk allele (95% confidence interval), as calculated by linear regression analysis, assuming an additive genetic model, with adjustment for age in stage
one, and for age, gender and ethnic group in stage two and in the combined analysis.
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near MC4R with waist circumference in stage two (Table 1); the most
strongly associated SNP was rs12970134. In the combined analysis of
stage one and two data, the association of three of these four SNPs
with waist circumference also reached genome-wide significance (Po
5  107, Table 1)7,8. There were no significant associations of the
remaining 18 SNPs with any of the phenotypes studied, either in stage
two, or in the combined analysis (Supplementary Table 2).
For participants included in stage two, we then examined the
association of the four SNPs near MC4R with the remaining
nine phenotypes (Table 2 and Supplementary Table 4 online),
adopting Po 0.006 to indicate statistical significance after Bonferroni
correction for the nine phenotypes tested. We found significant
associations of all four SNPs with HOMA-IR, waist-hip ratio, weight
and metabolic syndrome (Table 2 and Supplementary Table 4). The
association of rs12970134 with HOMA-IR persisted after adjustment
for waist, waist-hip ratio, or body mass index, and was also present
in non-obese and non-overweight individuals (body mass index
o25 kg/m2) (Supplementary Table 5 online), suggesting that the
relationship of rs12970134 with insulin resistance is in part indepen-
dent of adiposity. Results were also independent of treatment effects
(Supplementary Table 6 online).
SNPs rs12970134, rs4450508, rs477181 and rs502933 are in high
linkage disequilibrium (LD; r2 4 0.5) on chromosome 18, B150 kb
from MC4R (Supplementary Fig. 1 and Supplementary Table 7
online). MC4R is a plausible biological candidate for the association of
these four common SNPs with adiposity and insulin resistance. In
humans, multiple rare mutations conferring loss of function in MC4R
are associated with hyperphagia, severe childhood obesity and hyper-
insulinaemia9, a phenotype closely resembling that seen in the Mc4r–/–
mouse10. Experimental studies show that MC4R is a key regulator of
energy balance, influencing food intake and energy expenditure
through functionally divergent central melanocortin neuronal path-
ways11. Alterations in MC4R signaling affect glucose utilization and
insulin sensitivity12. MC4R and PMAIP1 (involved in p53-dependent
apoptosis), are the only protein-coding genes within 500 kb of the
four SNPs. Although we cannot exclude a role for PMAIP1, on the
basis of current knowledge of this region and strong biological
plausibility, we hypothesize that rs12970134, rs4450508, rs477181
and rs502933 may be markers of causal genetic variants in a regu-
latory region of MC4R. This is consistent with observations that
regulatory regions can be several hundred kilobases away from the
affected gene13.
We used imputation to further map SNP associations in this region
(Supplementary Methods). We identified a cluster of 133 SNPs
(including the four genotyped SNPs) in one LD block (r24 0.2) show-
ing significant association with waist circumference and HOMA-IR
(Supplementary Fig. 2 online), but no one signal predominated. We
also investigated potential regulatory features in the region of associa-
tion and identified a predicted small-nuclear RNA gene encoding a
putative U4 spliceosomal RNA, and predicted DNAse I hypersensitive
sites that might be involved in gene silencing by histone methylation14.
We did not find a relationship between the four SNPs and MC4R (or
PMAIP1) expression in peripheral blood mononuclear cells (P 4
0.24)15, which may reflect the predominant expression of MC4R in the
hypothalamus and other central nervous system (CNS) nuclei.
Homozygotes for the most strongly associated SNP, rs12970134,
have aB2 cm greater waist circumference andB10% higher HOMA-
IR compared with wild type. Risk allele frequencies of rs12970134 are
higher among individuals of Indian Asian ancestry than those of
European ancestry (36% vs. 27%, P ¼ 1050), as are those of the
other three genotyped SNPs (Supplementary Table 7). Our finding of
higher risk-allele frequencies among Indian Asians in SNPs near MC4R
suggests a possible genetic mechanism contributing to the increased
burden of central adiposity and insulin resistance in Indian Asians.
Note: Supplementary information is available on the Nature Genetics website.
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Table 2 Association of SNP rs12970134 (near MC4R) with insulin resistance and related phenotypes in stage two participants
Indian Asian ancestry
(n ¼ 7,394)
European ancestry
(n ¼ 4,561)
All stage two participants
(n ¼ 11,955)
Phenotype Effect size or OR (95% CI) P Effect size or OR (95% CI) P Effect size or OR (95% CI) P Heterogeneity P
HOMA-IR (%) 5.39 (2.78, 8.07) 4.2  105 5.16 (1.18, 9.29) 0.01 5.17 (2.96, 7.42) 3.2  106 0.95
Waist-hip ratio 0.004 (0.002, 0.006) 9.8 104 0.004 (0.000, 0.007) 0.02 0.004 (0.002, 0.006) 7.7  105 0.87
Weight (kg) 0.82 (0.40, 1.24) 1.3  104 1.21 (0.48, 1.94) 0.001 0.93 (0.56, 1.31) 1.0  106 0.37
Body mass index (kg/m2) 0.25 (0.10, 0.39) 6.8  104 0.28 (0.05, 0.51) 0.02 0.25 (0.13, 0.38) 6.4  105 0.86
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Metabolic syndrome 1.13 (1.05, 1.21) 0.002 1.13 (1.00, 1.27) 0.01 1.12 (1.06, 1.20) 2.3  104 0.93
Effect sizes are shown as unit or percentage change per copy of high-risk allele (A) for continuous traits and as odds ratio (OR) for categorical traits, as calculated by linear regression
analysis, assuming an additive genetic model, with adjustment for age in stage one, and for age, gender and ethnic group in stage two and in the combined analysis. HOMA-IR,
homeostasis model assessment of insulin resistance; HDL, high-density lipoprotein. Metabolic syndrome is as defined by Adult Treatment Panel III criteria5.
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